SBC Medical Group aims for new growth with NASDAQ listing
, expanding presence in global markets from aesthetic medicine to comprehensive medicine

Newly listed on NASDAQ in the US

SBC Medical Group Holdings (Headquarters: California, U.S.; CEO: Yoshiyuki Aikawa) will be listed on the U.S. NASDAQ and begin stock trading on September 18, 2024. Through this, the company will secure more diverse means of raising capital and aim to further accelerate its global expansion. We would like to express our sincere gratitude to all of our stakeholders who have supported us thus far, and we will continue to pursue growth.

History and growth of SBC Medical Group Holdings

SBC Medical Group Holdings, which originated from the Shonan Beauty Clinic, was founded in 2000 in Fujisawa City, Kanagawa Prefecture, and has provided advanced aesthetic medical services based on the philosophy of "making aesthetic medicine more accessible." Initially, we specialized in aesthetic medicine, but now we have expanded our business to a wide range of medical fields, including infertility treatment, dentistry, and orthopedic surgery, with 220 clinics in Japan and overseas (166 clinics excluding Rize Clinic and Gorilla Clinic). We operate a network of clinics.

Global expansion and franchise network expansion

With this listing on NASDAQ, SBC Medical Group Holdings aims to further expand into the US and Southeast Asian markets. By expanding our franchise clinics in Japan and overseas, we will provide high-quality medical services to more customers and increase recognition as a global brand.

SBC Medical Group Holdings' earnings model and management strategy

The company's stable revenue model based on consulting fees resulted in sales increasing by 11% and gross profit by 19% year-on-year in fiscal 2023. We will continue to pursue further growth by aiming to increase corporate value through strategic alliances and technological innovation.

Tackling intensifying competition and industry challenges

As the aesthetic medical care market expands, issues related to price competition and medical quality are becoming more apparent. SBC Medical Group Holdings strives to improve trust across the industry by promoting honest advertising, transparent pricing, and continuing physician education. We have also set up a "recommendation box" to receive feedback directly from customers in an effort to improve our services.

Comment from CEO Yoshiyuki Aikawa

Our company's management philosophy is ``Achieving the ultimate sampo-yoshi'', and we aim to be a medical group that pleases our customers, contributes to society, and where our staff can work with pride. We believe that this listing will support further growth for our company and will be a major step in enabling us to provide advanced consulting services not only in Japan but also to a global clinic network.

SBC Medical Group Holdings CEO Yoshiyuki Aikawa

Listing details information

• Listing market : NASDAQ Global Market
• Ticker symbol (stock code) : SBC
• Trading start date : Wednesday, September 18, 2024
• SBC Medical Group Holdings IR site : https://sbc-holdings.com/jp

Future prospects and goals

With this listing on NASDAQ as a new start, SBC Medical Group Holdings aims to expand its clinic network in Japan and overseas and grow as a global brand. We will continue to take on challenges as a company that realizes "sampo yoshi" for customers, society, and employees.

Contact information regarding this matter

SBC Medical Group Holdings
Location: 200 Spectrum Center Drive Suite 300 Irvine, CA 92618 USA
CEO: Yoshiyuki Aikawa
Business details: Management support business for medical institutions (comprehensive aesthetic medicine, dentistry, AGA treatment, gynecology, infertility treatment, ophthalmology, orthopedics) Surgery, regenerative medicine treatment, etc.)
Official website: https://sbc-holdings.com/jp

*SBC Medical Group: https://www.sbc-med.com/
*SBC Medical Group recruitment site: https://www.sbc-recruit.com/

■Press release source - SBC Medical Group Holdings Inc
https://companydata.tsujigawa.com/company/88-1263511/